These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5603842)

  • 1. [Clinical observations with a new combination of peripheral vasodilating agents].
    Dameno G
    Minerva Cardioangiol; 1967 Mar; 15(5):357-9. PubMed ID: 5603842
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rheocencephalographic changes in cerebral vascular diseases in the aged treated with the association of Raubasine and ergot alkaloids].
    Pasoli CA; Mansoldo G
    Minerva Cardioangiol; 1970 Apr; 18(4):267-71. PubMed ID: 5423416
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of phlebopathic dermatoses with a new drug combination].
    Altobella L
    Arch Ital Dermatol Venereol Sessuol; 1971; 37(1):49-54. PubMed ID: 5169778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peripheral hemodynamic criteria and blood flow stimulating vasoactive drugs in healthy persons and in patients with arterial obstruction of the extremities].
    Ehringer H
    Med Welt; 1969 Jan; 3():148-60. PubMed ID: 5764800
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psycho-geriatric utilization of a new pharmacologic association with vasodilative and vasosedative effects].
    Tàmmaro AE; Quadri A; Bonaccorso O
    Clin Ter; 1967 Jan; 40(1):63-7. PubMed ID: 5604248
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69].
    Laveant-Hebrard C; Camus JP
    Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transient cerebral ischemia: some clinico-therapeutic considerations in geriatrics].
    Turri C
    G Gerontol; 1970 Jan; 18(1):16-28. PubMed ID: 5523119
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of clinical trials of raubasin].
    Weidinger P
    Med Welt; 1970 Mar; 10():403-8. PubMed ID: 4908367
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
    Dabizzi RP; Fantini F; Cappelli G; Grandonico F
    Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with Rauwolfia alkaloid raubasin (Lamuran) in arterial, venous and lymphatic circulation disorders].
    Brembach H
    Med Welt; 1970 Feb; 6():240-3. PubMed ID: 5524036
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy in chronic organic brain syndrome--a review of the literature.
    Prien RF
    Psychopharmacol Bull; 1973 Oct; 9(4):5-20. PubMed ID: 4148528
    [No Abstract]   [Full Text] [Related]  

  • 12. [Report on the clinical testing of Lamuran (I)].
    Steinorth G
    Med Welt; 1967 Sep; 35():2025-32 contd. PubMed ID: 5595993
    [No Abstract]   [Full Text] [Related]  

  • 13. [Angiotics. 48. I. Hypertensive agents. II. Hypotensive agents. 3. Vasodilator agents. IV. Agents for the treatment of lipid metabolism disorders].
    Selchau M
    Pharm Prax; 1970; 9():200-16 contd. PubMed ID: 4320846
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunogram in different types of hypermetabolism.
    Mosonyi L; Dóbiás G; Gönczi J; Perényi E
    Acta Med Acad Sci Hung; 1970; 27(4):357-63. PubMed ID: 4102469
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with Lamuran in chronic arterious circulatory disorders and in a case of femoral embolism].
    Siebert U
    Z Allgemeinmed; 1972 Mar; 48(9):442-4. PubMed ID: 5034162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases].
    Dotti GC
    Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and laboratory observations on the use of a combination of methyclothiazide and deserpidine in treatment of essential hypertension.
    Shafei AZ; Abaza HH
    J Egypt Med Assoc; 1968; 51(1):48-56. PubMed ID: 4876817
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution to the clinical treatment of the varicose symptom complex].
    Sauerteig F
    Med Welt; 1966 Apr; 15():825-7. PubMed ID: 5951643
    [No Abstract]   [Full Text] [Related]  

  • 19. [The association of raubasine and ergot derivatives in therapy of peripheral vascular diseases].
    Sforza M; Perelli-Ercolini M
    Minerva Cardioangiol; 1967 Oct; 15(10):655-8. PubMed ID: 5611109
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experimentation of a new hypotensive medication. The combination of dimethylaminoethanol reserpilinate-hydrobenzthiazide].
    Fritel D
    Presse Med (1893); 1967 Feb; 75(6):289-90. PubMed ID: 6016652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.